AGM/EGMJul 23, 2026, 04:13 PM
CalciMedica Proposes Reverse Split, Equity Plan, Warrant Issuances
AI Summary
CalciMedica, Inc. announced its 2026 Annual Meeting of Stockholders to be held on August 19, 2026, where shareholders will vote on several key proposals. These include approving a reverse stock split at a ratio of 1-for-2 to 1-for-10, increasing the shares authorized under the 2023 Equity Incentive Plan by 7,500,000, and approving the issuance of Series A and B Warrants for a significant number of common shares. Additionally, shareholders will elect two Class III directors, ratify the independent auditor, and cast advisory votes on executive compensation.
Key Highlights
- Propose reverse stock split of common stock at a ratio of 1-for-2 to 1-for-10.
- Increase shares authorized under 2023 Equity Incentive Plan by 7,500,000 shares.
- Approve issuance of Series A Warrants for up to 18,673,429 shares.
- Approve issuance of Series B Warrants for up to 18,673,429 shares.
- Approve issuance of warrants to directors/officers for up to 3,361,130 shares.
- Elect two Class III directors for a three-year term.
- Ratify Baker Tilly US, LLP as independent auditor for fiscal year 2026.
- Fred Middleton to retire from the Board, reducing its size to seven directors.
Price Impact
More from CALC